Allegion CFO Michael Wagnes Executes Stock Option Exercises and Sells 3,184 Shares Under Pre-Arranged Rule 10b5-1 Plan

Coordinated Stock Option Exercise and Share Sale by CFO

Michael Wagnes, Allegion plc's Senior Vice President and Chief Financial Officer, executed a coordinated set of transactions on July 23, 2026, involving the exercise of stock options and the immediate sale of the corresponding shares. This simultaneous acquisition and sale strategy is commonly employed by executives to capitalize on vested options while managing their overall equity holdings.

The transactions were carried out pursuant to a Rule 10b5-1 trading plan adopted by Wagnes on September 12, 2025. Such plans enable insiders to set predetermined trading instructions during periods when they are not in possession of material non-public information, providing an affirmative defense against insider trading allegations. The pre-arranged nature means timing, quantity, and pricing decisions were made well in advance.

Details of Option Exercises and Pricing

The SEC filing reveals two separate option exercises on July 23, 2026. The first involved exercising 1,716 ordinary shares at a strike price of $71.835 per share, with these options having vested in equal installments on February 13 of 2018, 2019, and 2020. The second exercise covered 1,468 shares at a strike price of $86.93, vested annually on February 22 of 2019, 2020, and 2021.

Together, these exercises resulted in acquiring 3,184 shares. The strike prices reflect the fair market value at grant dates, consistent with standard equity compensation practices. While these exercises increased Wagnes' holdings, the subsequent sale of an equal number of shares on the same day resulted in no net change in his beneficial ownership.

Share Sales and Execution Prices

On July 23, 2026, Wagnes sold 3,184 Allegion ordinary shares at $150.98 each, significantly above the option strike prices. This price difference illustrates the gain realized through exercising options granted at lower prices and immediately liquidating the shares.

The sales were split into two lots matching the option exercises: 1,716 shares sold after the first exercise and 1,468 shares after the second. All shares sold were directly owned by Wagnes, as indicated by the "D" designation in the disclosure. These sales were also conducted under the same Rule 10b5-1 plan adopted on September 12, 2025, confirming both acquisition and disposition were pre-arranged.

Impact on Beneficial Ownership

After completing these transactions, Wagnes held 31,299 ordinary shares directly. This total reflects the offsetting effect of acquiring and selling 3,184 shares on July 23, 2026, resulting in no net change in share count. Despite this, the transactions enabled Wagnes to realize substantial economic gains by exercising options at lower strike prices and selling at the higher market price.

Investors often monitor such coordinated insider transactions for insights into management’s perspectives on share valuation and liquidity needs.

Rule 10b5-1 Trading Plan Compliance and Governance

Wagnes’ use of a Rule 10b5-1 trading plan aligns with corporate governance and insider trading compliance best practices. Authorized under Rule 10b5-1(c) of the Securities Exchange Act of 1934, these plans allow insiders to set predetermined trading instructions during periods when they lack material non-public information, reducing concerns about trade timing or motivations.

Adopted on September 12, 2025, Wagnes’ plan appears structured to allow periodic option exercises and share sales over a defined timeframe. The July 23, 2026 transactions were executed under this plan. By filing the Form 4, Allegion and Wagnes provide transparency about insider activity, demonstrating compliance and that trades were not influenced by undisclosed information.

Executive Compensation and Equity Incentives at Allegion

The disclosed option exercises represent standard executive compensation components at Allegion plc. Stock options serve as long-term incentives aligning executives’ interests with shareholders by granting options at fair market value and vesting over multiple years.

Wagnes held multiple option tranches granted at different times with varying strike prices and vesting schedules, consistent with typical multi-year compensation programs. Exercising fully vested options and selling underlying shares is a common liquidity management approach for executives with significant equity awards.

Regulatory Disclosure and Transparency

The Form 4 filing fulfills Wagnes’ obligations under Section 16(a) of the Securities Exchange Act of 1934, requiring officers and directors to report ownership changes within two business days. Filed on July 27, 2026, three business days after the transactions, the disclosure was executed by authorized representative Tandra M. Foster.

The filing provides detailed transparency, including transaction dates, codes, share quantities, prices, and resulting ownership. It clarifies that all option exercises and sales were conducted under the Rule 10b5-1 plan adopted September 12, 2025, ensuring investors have accurate insider trading information for informed decisions.

Investor Considerations

Investors in Allegion plc are advised to monitor ongoing insider trading by Wagnes and other executives. Although this coordinated exercise and sale was part of a pre-arranged plan and does not necessarily reflect views on the company’s outlook, patterns of insider transactions can offer valuable context when combined with other corporate and market data.

The immediate market impact of these transactions is unclear from public information. Investors should review these insider activities alongside company disclosures, earnings reports, and market trends to fully assess their implications.